Who is sponsoring NCT05823792?

NCT05823792 is sponsored by Hongkui Yu， MD.

What condition does NCT05823792 study?

NCT05823792 studies Ileocolic Intussusception.

Is NCT05823792 still recruiting?

NCT05823792 is currently status unknown. Last updated 21 April 2023.

Last reviewed 2023-04-21 · How we verify

NCT05823792: PAITUWDS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Performance of Artificial Intelligence Tools and Ultrasonographers With Different Skills

Status unknown Last updated 21 April 2023

What this trial tests

trial testing Non-invasive diagnosis of ileocolic intussusception by ultrasound with indication for surgery in Ileocolic Intussusception in 250 participants. Status unknown.

Timeline

9 April 2023

Primary endpoint
10 May 2023

10 May 2023

Quick facts

Lead sponsor	Hongkui Yu， MD
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	250
Start date	9 April 2023
Primary completion	10 May 2023
Estimated completion	10 May 2023
Sites	1 location across China

Drugs / interventions tested

Non-invasive diagnosis of ileocolic intussusception by ultrasound with indication for surgery

Conditions studied

Ileocolic Intussusception — all drugs for Ileocolic Intussusception →

Sponsor

Hongkui Yu， MD

Who can join

Adults 3 Months to 36 Months, any sex, with Ileocolic Intussusception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Artificial intelligence versus different skilled sonographers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05823792 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hongkui Yu， MD
Last refreshed: 21 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05823792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing